| Clinical characteristics of patients developing ARF due to sepsis/systemic inflammatory response syndrome: results of a prospective study I Yegenaga, E Hoste, W Van Biesen, R Vanholder, D Benoit, G Kantarci, ... American journal of kidney diseases 43 (5), 817-824, 2004 | 223 | 2004 |
| Relationship between fluid status and its management on acute renal failure (ARF) in intensive care unit (ICU) patients with sepsis: a prospective analysis. W Van Biesen, I Yegenaga, R Vanholder, F Verbeke, E Hoste, F Colardyn, ... Journal of nephrology 18 (1), 54-60, 2005 | 169 | 2005 |
| Renoprotective effects of valsartan and enalapril in STZ-induced diabetes in rats B Kalender, M Öztürk, M Tunçdemir, Ö Uysal, FK Dağıstanlı, I Yeğenağa, ... Acta histochemica 104 (2), 123-130, 2002 | 63 | 2002 |
| Diffusion magnetic resonance imaging may provide prognostic information in osmotic demyelination syndrome: report of a case E Dervisoglu, I Yegenaga, Y Anik, E Sengul, T Turgut Acta Radiologica 47 (2), 208-212, 2006 | 43 | 2006 |
| Evaluation of sepsis/systemic inflammatory response syndrome, acute kidney injury, and RIFLE criteria in two tertiary hospital intensive care units in Turkey I Yegenaga, S Tuglular, E Ari, N Etiler, N Baykara, S Torlak, S Acar, ... Nephron Clinical Practice 115 (4), c276-c282, 2010 | 36 | 2010 |
| Citrobacter freundii peritonitis and tunnel infection in a patient on continuous ambulatory peritoneal dialysis E Dervisoglu, Z Yumuk, I Yegenaga Journal of medical microbiology 57 (1), 125-127, 2008 | 20 | 2008 |
| Neutrophil gelatinase-associated lipocalin levels during the first 48 hours of intensive care may indicate upcoming acute kidney injury F Kamis, I Yegenaga, M Musul, C Baydemir, S Bek, B Kalender, ... Journal of critical care 34, 89-94, 2016 | 17 | 2016 |
| Neutrophil gelatinase-associated lipocalin is a better biomarker than cystatin C for the prediction of imminent acute kidney injury in critically ill patients I Yegenaga, F Kamis, C Baydemir, E Erdem, K Celebi, N Eren, N Baykara Annals of clinical biochemistry 55 (2), 190-197, 2018 | 12 | 2018 |
| Comparative proteome analysis of hAT-MSCs isolated from chronic renal failure patients with differences in their bone turnover status M Kasap, I Yeğenağa, G Akpinar, M Tuncay, A Aksoy, E Karaoz PLoS One 10 (11), e0142934, 2015 | 9 | 2015 |
| Peritonitis due to Pseudomonas putida in a Patient Receiving Automated Peritoneal Dialysis E Dervisoglu, DO Dundar, I Yegenaga, A Willke Infection 36, 379-380, 2008 | 9 | 2008 |
| Case Report: Peritonitis by Penicillium spp. in a Patient Undergoing Continuous Ambulatory Peritoneal Dialysis S Keceli, I Yegenaga, N Dagdelen, B Mutlu, H Uckardes, A Willke International urology and nephrology 37, 129-131, 2005 | 8 | 2005 |
| Acute kidney injury in Turkey: epidemiological characteristics, etiology, clinical course, and prognosis M Gursu, I Yegenaga, S Tuglular, B Dursun, SG Bek, S Bardak, E Onan, ... BMC nephrology 23 (1), 326, 2022 | 6 | 2022 |
| Study of hemodynamic disturbances during slow extended daily hemodialysis vs continuous renal replacement therapy in acute renal failure patients in the intensive care unit I Yegenaga, R Vanholder, E Hoste, B Van Vlem, N Lameire, F Colardyn Blood Purif 22, 240-241, 2004 | 5 | 2004 |
| Low Serum Zinc Level May be Related to Higher Doses of EPO in Hemodialysis Patients I Yegenaga, Z Aydin BANTAO Journal 12 (1), 40-44, 2014 | 3 | 2014 |
| ANCA associated vasculitis and renal failure related to propylthiouracil and hyperthyroidism induced cholestasis in the same case M Tuncay, E Kivrakoglu, I Yegenaga, E Dervisoglu Case Reports in Nephrology 2014, 2014 | 2 | 2014 |
| Hemodiyaliz ve Sürekli Ayaktan Periton Diyalizi İle Tedavi Edilen Son Dönem Böbrek Yetmezlikli Hastalarda Safra Kesesi Taşı Sıklığı Ö ŞENTÜRK, S HÜLAGÜ, Z CANTÜRK, A ÇELEBİ, Y KOÇANALI, ... Turkiye Klinikleri Journal of Gastroenterohepatology 11 (3), 123-126, 2000 | 1 | 2000 |
| Evaluation of Geographic and Clinical Differences of Acute Kidney Injury in Intensive Care Unit Patients in Turkey Running Head: AKI cases in intensive care units in Turkey I Yegenaga, M Gursu, S Tuglular, B Dursun, S Bardak, A Dogukan, S Bek, ... | | 2024 |
| Autoimmune Events after the COVID-19 Vaccination: Case Reports and Review I Yegenaga, FO Kaya, MY Tunc, XX Nermin, HT Kaloglu Ann Case Report 8, 1211, 2023 | | 2023 |
| Yoğun Bakım Hastalarında Akut Böbrek Hasarı I YEĞENAĞA Turkiye Klinikleri Nephrology-Special Topics 7 (1), 31-36, 2014 | | 2014 |
| Multidrug Resistance Associated with Acute Kidney Injury Due to Sepsis or Systemic Inflammatory Response Syndrome in Intensive Care Unit Patients/Yogun Bakim Ünitesi … SK Özcan, I Yegenaga, A Willke, N Baykara Türkiye Klinikleri. Tip Bilimleri Dergisi 33 (2), 485, 2013 | | 2013 |
Eric HosteGhent University Hospital, Ghent UniversityVerified email at ugent.be
